Reuters logo
BRIEF-Pharmena to present results of 1-MNA phase II clinical trials to pharmaceutical industry
October 5, 2016 / 9:06 AM / a year ago

BRIEF-Pharmena to present results of 1-MNA phase II clinical trials to pharmaceutical industry

Oct 5 (Reuters) - Pharmena SA :

* Starts process of presenting results of completed phase II clinical trials of anti-atherosclerosis 1-MNA drug to pharmaceutical industry for further commercialization with participation of pharmaceutical company Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below